146 related articles for article (PubMed ID: 31390899)
21. MicroRNA-556-3p promotes the progression of esophageal cancer via targeting DAB2IP.
Lu HB
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6816-6823. PubMed ID: 30402845
[TBL] [Abstract][Full Text] [Related]
22. ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients.
Ajani JA; Wang X; Song S; Suzuki A; Taketa T; Sudo K; Wadhwa R; Hofstetter WL; Komaki R; Maru DM; Lee JH; Bhutani MS; Weston B; Baladandayuthapani V; Yao Y; Honjo S; Scott AW; Skinner HD; Johnson RL; Berry D
Mol Oncol; 2014 Feb; 8(1):142-9. PubMed ID: 24210755
[TBL] [Abstract][Full Text] [Related]
23. MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma.
Song C; Lu P; Shi W; Sun G; Wang G; Huang X; Wang Z; Wang Z
Biomed Pharmacother; 2016 Oct; 83():843-849. PubMed ID: 27501502
[TBL] [Abstract][Full Text] [Related]
24. Introduction: Esophageal Adenocarcinoma: Updates of Current Status.
Lam AK
Methods Mol Biol; 2018; 1756():1-6. PubMed ID: 29600355
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic regulation on the gene expression signature in esophagus adenocarcinoma.
Xi T; Zhang G
Pathol Res Pract; 2017 Feb; 213(2):83-88. PubMed ID: 28049580
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype.
Lynam-Lennon N; Heavey S; Sommerville G; Bibby BA; Ffrench B; Quinn J; Gasch C; O'Leary JJ; Gallagher MF; Reynolds JV; Maher SG
Oncotarget; 2017 Feb; 8(7):11400-11413. PubMed ID: 28002789
[TBL] [Abstract][Full Text] [Related]
27. miR-625 down-regulation promotes proliferation and invasion in esophageal cancer by targeting Sox2.
Wang Z; Qiao Q; Chen M; Li X; Wang Z; Liu C; Xie Z
FEBS Lett; 2014 Mar; 588(6):915-21. PubMed ID: 24508466
[TBL] [Abstract][Full Text] [Related]
28. ROLE OF MICRORNA IN PREDICTING OF ADENOCARCINOMA DEVELOPMENT IN BARRETT’S ESOPHAGUS.
Tsitskarava AZ; Zaraiskiy MI; Vasilevskiy DI; Lapshin AS; Popova VF; Smirnov AA; Lyubchenko ME
Vestn Khir Im I I Grek; 2016; 175(4):13-4. PubMed ID: 30457256
[TBL] [Abstract][Full Text] [Related]
29. Aberrant methylation of microRNA-193b in human Barrett's esophagus and esophageal adenocarcinoma.
Lü L; Liu T; Gao J; Zeng H; Chen J; Gu X; Mei Z
Mol Med Rep; 2016 Jul; 14(1):283-8. PubMed ID: 27176876
[TBL] [Abstract][Full Text] [Related]
30. Detection and Quantification of MicroRNAs in Esophageal Adenocarcinoma.
Amin M; Islam F; Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():257-268. PubMed ID: 29600376
[TBL] [Abstract][Full Text] [Related]
31. microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma.
Matuszcak C; Lindner K; Eichelmann AK; Hussey DJ; Haier J; Hummel R
Surg Oncol; 2018 Sep; 27(3):392-401. PubMed ID: 30217293
[TBL] [Abstract][Full Text] [Related]
32. The expression of miR-21 and miR-375 predict prognosis of esophageal cancer.
Fu C; Dong W; Wang Z; Li H; Qin Q; Li B
Biochem Biophys Res Commun; 2014 Apr; 446(4):1197-203. PubMed ID: 24680681
[TBL] [Abstract][Full Text] [Related]
33. [Role of miRNA in the diagnosis, prognosis and treatment of esophageal cancer].
Cao XF; Li SQ
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):161-4. PubMed ID: 21575511
[No Abstract] [Full Text] [Related]
34. Involvement of microRNA-198 overexpression in the poor prognosis of esophageal cancer.
Qi B; Yao WJ; Zhao BS; Qin XG; Wang Y; Wang WJ; Wang TY; Liu SG; Li HC
Asian Pac J Cancer Prev; 2013; 14(9):5073-6. PubMed ID: 24175778
[TBL] [Abstract][Full Text] [Related]
35. Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer.
Tanaka K; Miyata H; Yamasaki M; Sugimura K; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S607-15. PubMed ID: 23838916
[TBL] [Abstract][Full Text] [Related]
36. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.
Warnecke-Eberz U; Chon SH; Hölscher AH; Drebber U; Bollschweiler E
Tumour Biol; 2015 Jun; 36(6):4643-53. PubMed ID: 25631748
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.
Drahos J; Schwameis K; Orzolek LD; Hao H; Birner P; Taylor PR; Pfeiffer RM; Schoppmann SF; Cook MB
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):429-37. PubMed ID: 26604271
[TBL] [Abstract][Full Text] [Related]
38. Serum miR-331-3p predicts tumor recurrence in esophageal adenocarcinoma.
Gu J; Zhang J; Zheng L; Ajani JA; Wu X; Ye Y
Sci Rep; 2018 Sep; 8(1):14006. PubMed ID: 30228315
[TBL] [Abstract][Full Text] [Related]
39. Silencing microRNA-330-5p increases MMP1 expression and promotes an invasive phenotype in oesophageal adenocarcinoma.
Bibby BAS; Miranda CS; Reynolds JV; Cawthorne CJ; Maher SG
BMC Cancer; 2019 Aug; 19(1):784. PubMed ID: 31391080
[TBL] [Abstract][Full Text] [Related]
40. Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma: loss of expression correlates with poor prognosis.
Darnton SJ; Hardie LJ; Muc RS; Wild CP; Casson AG
Int J Cancer; 2005 Jun; 115(3):351-8. PubMed ID: 15688381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
